11 March 2002
Effect of erythropoietin therapy and selenium supplementation on selected antioxidant parameters in blood of uremic patients on long-term hemodialysis.
Urszula Trafikowska, Anna Trafikowska, Andrzej Adamowicz, Bronisław Zachara, Jacek ManitiusMed Sci Monit 2002; 8(3): CR202-205 :: ID: 420901
Abstract
BACKGROUND: The kidney accumulates the highest level of selenium (Se) inthe organism and is the major source of plasma glutathione peroxidase (GSH-Px). Se, as an integral partof the active site of GSH-Px, plays an important role in protecting cell membranes from oxidative damage.Decreased blood Se levels and GSH-Px activity are common in chronic renal failure (CRF) patients. Ourstudy was an effort to evaluate the effect of erythropoietin (EPO) therapy and Se supplementation forCRF patients undergoing regular hemodialysis (HD) on blood Se, red cell glutathione (GSH), and bloodlipid peroxidation product levels, and on blood activity levels of GSH-Px and blood superoxide dismutase(SOD). MATERIAL/METHODS: Our subjects were divided into three groups: I - CRF patients on regular HDand EPO, II - HD patients receiving EPO and Se, and III - healthy controls. Se levels, SOD and GSH-Pxactivities were measured spectrofluorometrically, the GSH level by Beutler's colorimetric method, andlipid peroxidation products using TBARS. RESULTS: EPO therapy with Se supplementation significantly increasedwhole blood and plasma Se in HD patients, and raised red cell GSH-Px activity, but plasma GSH-Px activity,plasma superoxide dismutase, and plasma and red cell TBARS did not respond to Se supplementation. EPOalone showed no effect on these parameters. CONCLUSIONS: Treatment with EPO and supplementation withSe significantly increased the element concentration in whole blood and plasma, and GSH-Px activity inred cells. Plasma GSH-Px activity did not respond to Se.
Keywords: Adolescent, Dietary Supplements, Erythropoietin, Kidney Failure, Chronic, Renal Dialysis, Research Support, Non-U.S. Gov, Selenium, Spectrometry, Fluorescence, Time Factors, Uremia
Editorial
01 April 2024 : Editorial
Editorial: Forty Years of Waiting for Prevention and Cure of HIV Infection – Ongoing Challenges and Hopes for Vaccine Development and Overcoming Antiretroviral Drug ResistanceDOI: 10.12659/MSM.944600
Med Sci Monit 2024; 30:e944600
In Press
06 Mar 2024 : Clinical Research
Prevalence and Variation of Medical Comorbidities in Oral Surgery Patients: A Retrospective Study at Jazan ...Med Sci Monit In Press; DOI: 10.12659/MSM.943884
08 Mar 2024 : Clinical Research
Evaluation of Foot Structure in Preschool Children Based on Body MassMed Sci Monit In Press; DOI: 10.12659/MSM.943765
15 Apr 2024 : Laboratory Research
The Role of Copper-Induced M2 Macrophage Polarization in Protecting Cartilage Matrix in OsteoarthritisMed Sci Monit In Press; DOI: 10.12659/MSM.943738
07 Mar 2024 : Clinical Research
Knowledge of and Attitudes Toward Clinical Trials: A Questionnaire-Based Study of 179 Male Third- and Fourt...Med Sci Monit In Press; DOI: 10.12659/MSM.943468
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952